Alzheimer drug Leqembi: the twice-monthly infusion could be available in injection form

Makers of the new Alzheimer's drug Leqembi say their twice-monthly infusion could be available in injection form at pharmacies by early 2025 — if all goes well in ongoing trials and the regulatory process. Eisai and Biogen (BIIB), co-developers of the recently approved intravenous (IV) drug,…

#leqembi #eisai #biogen #biib #iv #goldmansachs #alexscott #yahoofinance #dallas #labcorp